Morgan Stanley filed applications for Ethereum and Solana ETFs with a 0.14% fee https://ymaho.com/morgan-stanley-filed-applications-for-ethereum-and-solana-etfs-with-a-0-14-fee
Morgan Stanley filed applications for Ethereum and Solana ETFs with a 0.14% fee and staking. Learn how this will change the crypto-ETF market and affect investors.
Pediatric Dovato: ViiV application and geopolitics of the HIV market https://ymaho.com/pediatric-dovato-viiv-application-and-geopolitics-of-the-hiv-market
ViiV has submitted applications to the FDA and EMA for dispersible Dovato tablets for children. We analyze the strategy, patents, and implications. Find out who will win.
Revision of MiCA: why ART stablecoins did not take off https://ymaho.com/revision-of-mica-why-art-stablecoins-did-not-take-off
The European Commission has started a revision of MiCA due to zero applications for ARTs. Reasons for failure and forecasts for stablecoins. Find out what will change by 2027.
Blockchain IoT Explained Simply: Real-World Device Connections https://ymaho.com/blockchain-iot-explained-simply-real-world-device-connections
How everyday devices connect to blockchains using sidechains and cross-chain tech. Understand IoT blockchain applications in plain English.
Russian mRNA cancer vaccine included in 2026 state guarantee program https://ymaho.com/russian-mrna-cancer-vaccine-included-in-2026-state-guarantee-program
Gamaleya and FMBA cancer vaccines will become free under compulsory health insurance. CAR-T for 7 million rubles and personalized course for 5.8 million. Find out who is eligible for Oncopept and how many applications have already been approved.
How Does Blockchain Technology Work? Beginner Guide https://ymaho.com/how-does-blockchain-technology-work-beginner-guide
Learn how does blockchain technology work in this complete beginner's guide. Discover key concepts, real-world applications, and why it matters for your future.
Why Betting 'No' Wins Most Prediction Markets https://ymaho.com/why-betting-no-wins-most-prediction-markets
73% of prediction market bets end in 'No.' Learn why doing nothing often beats betting on change—and what it means for you.
Pediatric Dovato: EMA Approves Application for HIV Therapy https://ymaho.com/pediatric-dovato-ema-approves-application-for-hiv-therapy
EMA validated the application for pediatric Dovato (dolutegravir/lamivudine) for children from 2 years old. Learn how two-drug therapy is changing HIV treatment standards.
EMA accepted the application for Dovato for children with HIV https://ymaho.com/ema-accepted-the-application-for-dovato-for-children-with-hiv
EMA validated the application for the use of Dovato in children from 3 months with HIV. Learn how this will change pediatric therapy and strengthen ViiV's position. Read the detailed analysis.
Study of the Ottava robot: FORTE results and FDA application https://ymaho.com/study-of-the-ottava-robot-forte-results-and-fda-application
Scientists have completed the pivotal study of the Ottava robot (FORTE) and are preparing an FDA application. Learn about clinical data, zero conversions, and market prospects for robotic surgery.